{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:08:43Z","timestamp":1791263323042,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01937-z","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T02:40:22Z","timestamp":1763433622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated bulk and single-cell transcriptomic profiling reveals NECTIN\u2013TIGIT interaction underlies T cell exhaustion in papillary thyroid carcinoma"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8929-8381","authenticated-orcid":false,"given":"Ahmad","family":"Golestanifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-7826","authenticated-orcid":false,"given":"Mohammad Reza","family":"Seyedtaghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-7561","authenticated-orcid":false,"given":"Pegah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"3","key":"1937_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12020-023-03336-4","volume":"80","author":"F Basolo","year":"2023","unstructured":"Basolo F, et al. The 5(th) edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma. Endocrine. 2023;80(3):470\u20136.","journal-title":"Endocrine"},{"key":"1937_CR2","doi-asserted-by":"publisher","first-page":"1139362","DOI":"10.3389\/fmed.2023.1139362","volume":"10","author":"VA Ruiz-Pozo","year":"2023","unstructured":"Ruiz-Pozo VA, et al. Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer. Front Med (Lausanne). 2023;10:1139362.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"1937_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","volume":"31","author":"CM Kitahara","year":"2022","unstructured":"Kitahara CM, Schneider AB. Epidemiology of Thyroid Cancer. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1284\u201397.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"1937_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12020-023-03415-6","volume":"81","author":"AK Murugan","year":"2023","unstructured":"Murugan AK, Alzahrani AS. Potential impacts of SARS-CoV-2 on parathyroid: current advances and trends. Endocrine. 2023;81(3):391\u2013408.","journal-title":"Endocrine"},{"issue":"3","key":"1937_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7150\/ijms.29935","volume":"16","author":"MI Abdullah","year":"2019","unstructured":"Abdullah MI, et al. Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci. 2019;16(3):450\u201360.","journal-title":"Int J Med Sci"},{"key":"1937_CR6","doi-asserted-by":"crossref","unstructured":"Murugan AK. PI3K\/Akt signaling in human cancer. In: Seminars in cancer biology. 2019.","DOI":"10.1016\/j.semcancer.2019.10.022"},{"issue":"1","key":"1937_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12967-016-0958-x","volume":"14","author":"AK Murugan","year":"2016","unstructured":"Murugan AK, et al. Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer. J Transl Med. 2016;14(1):204.","journal-title":"J Transl Med"},{"issue":"7","key":"1937_CR8","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/jcp.25269","volume":"231","author":"AK Murugan","year":"2016","unstructured":"Murugan AK, Munirajan AK, Alzahrani AS. Micrornas: modulators of the Ras oncogenes in oral cancer. J Cell Physiol. 2016;231(7):1424\u201331.","journal-title":"J Cell Physiol"},{"key":"1937_CR9","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.3389\/bjbs.2021.10208","volume":"79","author":"A Murugan","year":"2022","unstructured":"Murugan A, Alzahrani A. Isocitrate dehydrogenase IDH1 and IDH2 mutations in human cancer: prognostic implications for gliomas. Br J Biomed Sci. 2022;79:10208.","journal-title":"Br J Biomed Sci"},{"issue":"4","key":"1937_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1937_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. 2018;33(4):547\u201362.","journal-title":"Cancer Cell"},{"issue":"8","key":"1937_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1937_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2326","volume":"8","author":"W Zou","year":"2008","unstructured":"Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol. 2008;8(6):467\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"1937_CR14","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41417-023-00663-6","volume":"30","author":"C Feng","year":"2023","unstructured":"Feng C, et al. Integrative single-cell transcriptome analysis reveals immune suppressive landscape in the anaplastic thyroid cancer. Cancer Gene Ther. 2023;30(12):1598\u2013609.","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"1937_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/1759-7714.15243","volume":"15","author":"H Zhou","year":"2024","unstructured":"Zhou H, et al. Single-cell sequencing reveals the immune landscape of breast cancer patients with brain metastasis. Thorac Cancer. 2024;15(9):702\u201314.","journal-title":"Thorac Cancer"},{"issue":"5","key":"1937_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","volume":"20","author":"T Stuart","year":"2019","unstructured":"Stuart T, Satija R. Integrative single-cell analysis. Nat Rev Genet. 2019;20(5):257\u201372.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"1937_CR17","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41588-020-00726-6","volume":"52","author":"GS Kinker","year":"2020","unstructured":"Kinker GS, et al. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat Genet. 2020;52(11):1208\u201318.","journal-title":"Nat Genet"},{"issue":"1","key":"1937_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174.","journal-title":"Genome Biol"},{"issue":"1","key":"1937_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR20","unstructured":"Oliveros JC. Venny. An interactive tool for comparing lists with venn\u2019s diagrams. (2007\u20132015); Available from: https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html."},{"issue":"W1","key":"1937_CR21","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216-w221.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR22","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447\u201352.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"1937_CR24","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, et al. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(4):S11.","journal-title":"BMC Syst Biol"},{"key":"1937_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"issue":"6220","key":"1937_CR26","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, et al. Proteomics tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"},{"issue":"1","key":"1937_CR27","doi-asserted-by":"publisher","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"CJ Liu","year":"2023","unstructured":"Liu CJ, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24(1):bbac558.","journal-title":"Brief Bioinform"},{"issue":"2","key":"1937_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42(2):293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"1937_CR29","doi-asserted-by":"crossref","unstructured":"Germain PL et al. Doublet identification in single-cell sequencing data using scDblFinder. F1000Research. 2021.","DOI":"10.12688\/f1000research.73600.1"},{"issue":"2","key":"1937_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"key":"1937_CR31","doi-asserted-by":"crossref","unstructured":"Jin S, MV Plikus, and Q Nie. CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics. bioRxiv. 2023 p.565674","DOI":"10.1101\/2023.11.05.565674"},{"issue":"11","key":"1937_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, et al. SRplot: a free online platform for data visualization and graphing. PLoS ONE. 2023;18(11):e0294236.","journal-title":"PLoS ONE"},{"issue":"11","key":"1937_CR33","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"3","key":"1937_CR34","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1937_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215567","author":"S Ulisse","year":"2021","unstructured":"Ulisse S, et al. Papillary thyroid cancer prognosis: an evolving field. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13215567.","journal-title":"Cancers (Basel)"},{"key":"1937_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.871085","volume":"12","author":"T Annese","year":"2022","unstructured":"Annese T, Tamma R, Ribatti D. Update in TIGIT immune-checkpoint role in cancer. Front Oncol. 2022;12:871085.","journal-title":"Front Oncol"},{"key":"1937_CR37","doi-asserted-by":"publisher","first-page":"1568664","DOI":"10.3389\/fphar.2025.1568664","volume":"16","author":"K Ghasemi","year":"2025","unstructured":"Ghasemi K. Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy. Front Pharmacol. 2025;16:1568664.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1937_CR38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/ph14030200","volume":"14","author":"J Yeo","year":"2021","unstructured":"Yeo J, et al. TIGIT\/CD226 Axis regulates anti-tumor immunity. Pharmaceuticals (Basel). 2021;14(3):200.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"1937_CR39","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1038\/s41467-023-40755-3","volume":"14","author":"JD Worboys","year":"2023","unstructured":"Worboys JD, et al. TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation. Nat Commun. 2023;14(1):5016.","journal-title":"Nat Commun"},{"issue":"4","key":"1937_CR40","doi-asserted-by":"publisher","first-page":"e004711","DOI":"10.1136\/jitc-2022-004711","volume":"10","author":"EY Chiang","year":"2022","unstructured":"Chiang EY, Mellman I. TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy. J Immunother Cancer. 2022;10(4):e004711.","journal-title":"J Immunother Cancer"},{"key":"1937_CR41","doi-asserted-by":"publisher","first-page":"10041","DOI":"10.2147\/CMAR.S239515","volume":"11","author":"RT Hao","year":"2019","unstructured":"Hao RT, et al. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT. Cancer Manag Res. 2019;11:10041\u20132.","journal-title":"Cancer Manag Res."},{"issue":"2","key":"1937_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1158\/1078-0432.CCR-08-0933","volume":"15","author":"YC Henderson","year":"2009","unstructured":"Henderson YC, et al. High rate of BRAF and RET\/PTC dual mutations associated with recurrent papillary thyroid carcinoma. Clin Cancer Res. 2009;15(2):485\u201391.","journal-title":"Clin Cancer Res"},{"key":"1937_CR43","unstructured":"Guerra A, et al. Simultaneous occurrence of BRAF mutation and RET\/PTC rearrangement is frequent in papillary thyroid carcinoma. In: endocrine abstract. Bioscientifica.2012."},{"issue":"1","key":"1937_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mce.2009.10.016","volume":"321","author":"M Saji","year":"2010","unstructured":"Saji M, Ringel MD. The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors. Mol Cell Endocrinol. 2010;321(1):20\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"1937_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1089\/thy.2010.1646","volume":"20","author":"M Xing","year":"2010","unstructured":"Xing M. Genetic alterations in the phosphatidylinositol-3 kinase\/Akt pathway in thyroid cancer. Thyroid. 2010;20(7):697\u2013706.","journal-title":"Thyroid"},{"issue":"1","key":"1937_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1677\/ERC-08-0251","volume":"17","author":"N Burrows","year":"2010","unstructured":"Burrows N, et al. Expression of hypoxia-inducible factor 1\u03b1 in thyroid carcinomas. Endocr Relat Cancer. 2010;17(1):61.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"1937_CR47","volume":"2011","author":"N Burrows","year":"2011","unstructured":"Burrows N, et al. Hypoxia-inducible factor in thyroid carcinoma. J Thyroid Res. 2011;2011(1):762905.","journal-title":"J Thyroid Res"},{"issue":"6","key":"1937_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3349\/ymj.2015.56.6.1503","volume":"56","author":"YJ Yang","year":"2015","unstructured":"Yang YJ, et al. Hypoxia induces epithelial-mesenchymal transition in follicular thyroid cancer: involvement of regulation of twist by hypoxia inducible factor-1\u03b1. Yonsei Med J. 2015;56(6):1503\u201314.","journal-title":"Yonsei Med J"},{"issue":"5","key":"1937_CR49","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3892\/or.2017.5972","volume":"38","author":"M Nowacka-Zawisza","year":"2017","unstructured":"Nowacka-Zawisza M, Wi\u015bnik E. DNA methylation and histone modifications as epigenetic regulation in prostate cancer. Oncol Rep. 2017;38(5):2587\u201396.","journal-title":"Oncol Rep"},{"issue":"2","key":"1937_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/bmc-2013-0036","volume":"5","author":"F Gao","year":"2014","unstructured":"Gao F, Das SK. Epigenetic regulations through DNA methylation and hydroxymethylation: clues for early pregnancy in decidualization. Biomol Concepts. 2014;5(2):95\u2013107.","journal-title":"Biomol Concepts"},{"issue":"699895","key":"1937_CR51","first-page":"2021","volume":"12","author":"Z Ge","year":"2021","unstructured":"Ge Z, et al. TIGIT, the next step towards successful combination immune checkpoint therapy in cancer. Front Immunol. 2021;12(699895):2021.","journal-title":"Front Immunol"},{"issue":"3","key":"1937_CR52","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/ERC-13-0431","volume":"21","author":"LL Cunha","year":"2014","unstructured":"Cunha LL, Marcello MA, Ward LS. The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr Relat Cancer. 2014;21(3):R85\u2013103.","journal-title":"Endocr Relat Cancer"},{"issue":"16","key":"1937_CR53","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.7150\/jca.44506","volume":"11","author":"H Yin","year":"2020","unstructured":"Yin H, et al. Immune microenvironment of thyroid cancer. J Cancer. 2020;11(16):4884.","journal-title":"J Cancer"},{"key":"1937_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091277","author":"A Rotte","year":"2021","unstructured":"Rotte A, Sahasranaman S, Budha N. Targeting TIGIT for immunotherapy of cancer: update on clinical development. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9091277.","journal-title":"Biomedicines"},{"issue":"2","key":"1937_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000957","volume":"8","author":"J-M Chauvin","year":"2020","unstructured":"Chauvin J-M, Zarour HM. Tigit in cancer immunotherapy. J Immunother Cancer. 2020;8(2):e000957.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"1937_CR56","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","volume":"14","author":"J Fang","year":"2023","unstructured":"Fang J, et al. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications. Cell Death Dis. 2023;14(9):586.","journal-title":"Cell Death Dis"},{"issue":"7","key":"1937_CR57","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-023-05961-3","volume":"14","author":"W Tang","year":"2023","unstructured":"Tang W, et al. TIGIT, a novel immune checkpoint therapy for melanoma. Cell Death Dis. 2023;14(7):466.","journal-title":"Cell Death Dis"},{"issue":"11","key":"1937_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003134","volume":"9","author":"S Kawashima","year":"2021","unstructured":"Kawashima S, et al. TIGIT\/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment. J Immunother Cancer. 2021;9(11):e003134.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1937_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40364-023-00543-z","volume":"12","author":"P Zhang","year":"2024","unstructured":"Zhang P, et al. Targeting TIGIT for cancer immunotherapy: recent advances and future directions. Biomark Res. 2024;12(1):7.","journal-title":"Biomark Res"},{"issue":"12","key":"1937_CR60","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s43018-024-00870-6","volume":"5","author":"K Nutsch","year":"2024","unstructured":"Nutsch K, et al. Tigit and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation. Nat Cancer. 2024;5(12):1834\u201351.","journal-title":"Nat Cancer"},{"key":"1937_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699895","volume":"12","author":"Z Ge","year":"2021","unstructured":"Ge Z, et al. TIGIT, the next step towards successful combination immune checkpoint therapy in cancer. Front Immunol. 2021;12:699895.","journal-title":"Front Immunol"},{"issue":"23","key":"1937_CR62","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.3390\/cancers14235757","volume":"14","author":"A Paw\u0142owska","year":"2022","unstructured":"Paw\u0142owska A, et al. The dual blockade of the TIGIT and PD-1\/PD-L1 pathway as a new hope for ovarian cancer patients. Cancers. 2022;14(23):5757.","journal-title":"Cancers"},{"issue":"6","key":"1937_CR63","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(22)00226-1","volume":"23","author":"BC Cho","year":"2022","unstructured":"Cho BC, et al. Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. Lancet Oncol. 2022;23(6):781\u201392.","journal-title":"Lancet Oncol"},{"issue":"28","key":"1937_CR64","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1080\/14796694.2024.2355863","volume":"20","author":"S Badhrinarayanan","year":"2024","unstructured":"Badhrinarayanan S, et al. IMbrave152\/SKYSCRAPER-14: a phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma. Future Oncol. 2024;20(28):2049\u201357.","journal-title":"Future Oncol"},{"issue":"27","key":"1937_CR65","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1080\/14796694.2024.2343272","volume":"20","author":"R Shapira-Frommer","year":"2024","unstructured":"Shapira-Frommer R, et al. The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies. Future Oncol. 2024;20(27):1983\u201391.","journal-title":"Future Oncol"},{"issue":"3","key":"1937_CR66","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1200\/JCO.23.01363","volume":"42","author":"CM Rudin","year":"2024","unstructured":"Rudin CM, et al. SKYSCRAPER-02: tiragolumab in combination with atezolizumab plus chemotherapy in untreated extensive-stage small-cell lung cancer. J Clin Oncol. 2024;42(3):324\u201335.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1937_CR67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12672-020-00390-6","volume":"11","author":"L MacDonald","year":"2020","unstructured":"MacDonald L, et al. The thyroid tumor microenvironment: potential targets for therapeutic intervention and prognostication. Horm Cancer. 2020;11(5):205\u201317.","journal-title":"Horm Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01937-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01937-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01937-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:09:02Z","timestamp":1763446142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01937-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01937-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"13"}}